CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Resources

We found 6932 result(s)

Terms of Use

Published on: March 8, 2006
Result type: General Content

Collection CADTH publishes a variety of health technology assessments and other materials, and makes them available on this website. Use of the website and material on the website is governed by these Terms of Use. CADTH reserves the right to amend or modify these Terms of Use at any time, without notice. The current version of these Terms of U...

infliximab (Renflexis)

Last Updated: November 5, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: infliximab
Indications: rheumatoid arthritis, ankylosing spondylitis, adult Crohn’s disease, pediatric Crohn’s disease, fistulising Crohn’s disease, adult ulcerative colitis, pediatric ulcerative colitis, psoriatic arthritis, plaque psoriasis

  • Brand Name: Renflexis
  • Manufacturer: Merck Canada Inc.
  • Project Number: SE0532-000
  • Project Status: Complete
  • Submission Type: New

reslizumab (Cinqair)

Last Updated: November 5, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: reslizumab
Indications: Asthma, eosinophilic

  • Brand Name: Cinqair
  • Manufacturer: TEVA Canada Innovation
  • Project Number: SF0591-000
  • Project Status: Complete
  • Submission Type: Request For Advice

A Transdermal Glucagon Patch for Severe Hypoglycemia

Last Updated: June 19, 2017
Result type: Reports
opens in document viewer

The ZP-Glucagon patch uses novel microneedle technology to deliver glucagon through the skin to people who are experiencing severe hypoglycemia (very low blood sugar). There is very limited evidence, from one small study, comparing the ZP-Glucagon patch with glucagon injected intramuscularly. The evidence suggests that the correction of blood...

  • Project Number: EH0054-000

Injectable Extended-Release Naltrexone to Treat Opioid Use Disorder

Last Updated: August 10, 2017
Result type: Reports
opens in document viewer

Vivitrol is an extended-release injectable formulation of naltrexone, administered as an intramuscular injection once a month. Naltrexone is an opioid-receptor antagonist that blocks the euphoric effects of opioids. Unlike other treatments for opioid use disorder, including buprenorphine/naloxone and methadone, naltrexone is not associated wi...

  • Project Number: EH0058-000

RSS Feeds

Published on: July 26, 2007
Result type: General Content

RSS stands for “Rich Site Summary”, “RDF Site Summary”, or “Real Simple Syndication” — a commonly used protocol originally developed to facilitate the syndication and sharing of news articles. RSS is an XML-based summary of a web site, usually used for syndication and other kinds of content-sharing. There are RSS "feeds", which are sources of RS...

A Hybrid Closed-Loop Insulin Delivery System for the Treatment of Type 1 Diabetes

Last Updated: June 14, 2017
Result type: Reports
opens in document viewer

Because their bodies no longer produce enough insulin, people with type 1 diabetes mellitus must check their blood glucose — or blood sugar — levels several times a day and then calculate and inject an appropriate insulin dosage. Wearable systems, sometimes referred to as an “artificial pancreas,” are now available to replicate some of the fu...

  • Project Number: EH0052-000

Mobile Stroke Units for Prehospital Care of Ischemic Stroke

Last Updated: June 5, 2017
Result type: Reports
opens in document viewer

Stroke is a leading cause of death and disability in Canada, and early diagnosis and treatment are essential to improving patient outcomes. Mobile stroke units are similar to ambulances but are equipped with a portable computed tomography (CT) scanner and specially trained staff for the rapid diagnosis and treatment of ischemic stroke. Eviden...

  • Project Number: EH0047-000